VEGFA and hepatocellular carcinoma: The effectiveness of LY2157299 and LY2109761 in inhibiting HCC cell migration, and pSMAD2, E-cadherin, VEGF and CTGF dephosphorylation, imply that both molecules share similar activity profiles [13], [20].